the right choice depends on the studys tolerance for injection-related handling, the need for exact receptor selectivity, and whether absorption route itself is a study variable
doi:10.1007/s00011-013-0671-7 Plummer JL, Smith BR, Sies H, Bend JR (1981) Chemical depletion of glutathione in vivo
Exendin-4 thus became the molecular blueprint for exenatide, the first twice-daily injectable GLP-1 receptor agonist, approved by the FDA in 2005
Their major limitation is hypoglycemia, particularly in older adults
BPC-157 is part of a growing list of compounds called peptides gaining interest in fitness, wellness, and antiaging circles
Factors Affecting Pharmacokinetics Limited data exists regarding factors potentially affecting BPC-157 pharmacokinetics in human subjects